Skip to main content
    M

    Mainz Biomed BV (MYNZ)

    Official site

    DIAGNOSTICS & RESEARCH

    $0.58
    -0.05 (-7.58%)

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Mainz Biomed BV (MYNZ) Stock Chart

    Updated Nov 16, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Mainz Biomed BV (MYNZ) closed at $0.58 on Nov 16, 2026. Its price fell 43.2% over the 12 months through Oct 2026. The month-end price fell 99.0% over the 3 years through Oct 2026, a compound annual decline of 78.1%.

    Price Chart

    From Nov 2021 to Oct 2026, its highest month-end close was $628.80 in Jan 2022 and its lowest $0.43 in Apr 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MYNZ with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MYNZ.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 59.1%, and over 6 months it fell 82.3%.

    PeriodChange
    1 month-44.8%
    3 months-59.1%
    6 months-82.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    1 year-43.2%-43.2%
    3 years-99.0%-78.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price fell 31.7%, and its weakest was 2024, when it fell 90.7%.

    YearCloseChange
    2026 through Oct 2026$0.84-25.0%
    2025$1.12-74.1%
    2024$4.32-90.7%
    2023$46.40-83.7%
    2022$284.00-31.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 46.5% below its 50-day average of $1.09 and 50.6% below its 200-day average of $1.18.

    MeasureValuePrice vs
    Close (Nov 16, 2026)$0.58
    50-day average$1.09-46.5%
    200-day average$1.18-50.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.5%.

    MeasureValue
    1-year beta2.49
    Largest fall, 1 year-84.1%
    Largest fall, 3 years-99.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MYNZ

    What is MYNZ's 1-year price change?

    Mainz Biomed BV's price fell 43.2% over the 12 months through Oct 2026.

    How has MYNZ stock done over the long term?

    Mainz Biomed BV's month-end price fell 99.0% over the 3 years through Oct 2026, a compound annual decline of 78.1%. These figures leave out dividends.

    What is MYNZ's beta?

    Mainz Biomed BV's 1-year beta against the S&P 500 is 2.49, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 84.1%.

    Is the MYNZ chart free?

    Yes. Advanced Charting for MYNZ is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.